Mad Money w/Jim Cramer 4/17/23

from Mad Money w/ Jim Cramer · host CNBC

The averages rose to start the week and Jim Cramer is helping investors navigate the market's moves. First up, fresh off the announcement that Merck will buy Prometheus Biosciences for $11b, Cramer's talking to Merck CEO Rob Davis and Prometheus CEO Mark McKenna to dig deeper into what the deal will mean for investors and patients. Then, the S&P has climbed 8% this year, but is more upside ahead? Cramer's going Off The Charts to find out. Plus, Cramer's exclusive with InMode CEO Moshe Mizrahy. Mad Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Apr 17, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Mad Money w/Jim Cramer 4/17/23

0:00 45:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Mad Money w/ Jim Cramer?

This episode is 45 minutes long.

When was this Mad Money w/ Jim Cramer episode published?

This episode was published on April 17, 2023.

Can I download this Mad Money w/ Jim Cramer episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!